Why Sarepta Therapeutics Shares Are Suddenly Dropping

Sarepta Therapeutics ( (SRPT) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.

Claim 30% Off TipRanks

Sarepta Therapeutics is sliding today as traders take money off the table after yesterday’s powerful rally, which was driven by excitement over early clinical data from its siRNA drug programs. The pullback reflects growing concern that the recent surge ran ahead of what the limited patient data and early biomarker signals can justify.

Adding to the pressure, analysts turned more cautious, spotlighting the risks of betting heavily on such early-stage results. Deutsche Bank kept its Sell rating and argued that the latest run-up looked stretched, while Needham also urged restraint, casting doubt on the durability of the recent gains.

More about Sarepta Therapeutics

YTD Price Performance: 10.46%

Average Trading Volume: 2,890,763

Technical Sentiment Signal: Sell

Current Market Cap: $2.5B

For further insights into SRPT stock on TipRanks’ Stock Analysis page.

See more of today’s top stock gainers and losers.